We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
-46.01%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
-$4.75M
Cap. Flow
-$9.34M
Cap. Flow %
-6.13%
Top 10 Hldgs %
27.08%
Holding
220
New
35
Increased
52
Reduced
54
Closed
46

Top Buys

Rank Stock Value
1
TTSH
Tile Shop Holdings
TTSH
+$1.86M
2
TGLS icon
Tecnoglass
TGLS
+$1.3M
3
VRSK icon
Verisk Analytics
VRSK
+$938K
4
GPN icon
Global Payments
GPN
+$842K
5
BLZE icon
Backblaze
BLZE
+$763K

Top Sells

Rank Stock Value
1
BCS icon
Barclays
BCS
+$1.57M
2
SYNA icon
Synaptics
SYNA
+$1.45M
3
LYG icon
Lloyds Banking Group
LYG
+$1.04M
4
ASO icon
Academy Sports + Outdoors
ASO
+$966K
5
BXC icon
BlueLinx
BXC
+$855K

Sector Composition

Rank Sector Weight
1 Technology 26.32%
2 Industrials 17.64%
3 Consumer Discretionary 14.66%
4 Financials 10.09%
5 Healthcare 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASO icon
101
Academy Sports + Outdoors
ASO
$3.04B
$471K 0.31%
10,720
-22,240
-67% -$966K
AOUT icon
102
American Outdoor Brands
AOUT
$158M
$456K 0.3%
22,900
+5,000
+28% +$112K
NWG icon
103
NatWest
NWG
$69.9B
$456K 0.3%
138,680
-116,072
-46% -$754K
KZR
104
DELISTED
Kezar Life Sciences
KZR
$452K 0.3%
2,703
-2,132
-44% -$241K
MGNI icon
105
Magnite
MGNI
$2.83B
$451K 0.3%
+25,750
New +$580K
CSLT
106
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$445K 0.29%
288,930
+30,659
+12% +$50.6K
ZGNX
107
DELISTED
Zogenix, Inc.
ZGNX
$443K 0.29%
27,269
-11,401
-29% -$167K
CRL icon
108
Charles River Laboratories
CRL
$11.3B
$439K 0.29%
+1,164
New +$452K
SKIN icon
109
SkinHealth Systems
SKIN
$83.4M
$430K 0.28%
17,808
+3,746
+27% +$96.5K
XOP icon
110
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
$426K 0.28%
+4,447
New +$456K
ARCO icon
111
Arcos Dorados Holdings
ARCO
$1.74B
$414K 0.27%
+70,951
New +$360K
BX icon
112
Blackstone
BX
$104B
$414K 0.27%
3,196
-496
-13% -$66.1K
NVDA icon
113
NVIDIA
NVDA
$4.6T
$410K 0.27%
13,940
-8,360
-37% -$230K
ALNY icon
114
Alnylam Pharmaceuticals
ALNY
$38.3B
$407K 0.27%
+2,398
New +$446K
KALV
115
DELISTED
KalVista Pharmaceuticals
KALV
$407K 0.27%
30,763
+10,697
+53% +$170K
MAXR
116
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$399K 0.26%
13,500
-1,500
-10% -$43.5K
LMT icon
117
Lockheed Martin
LMT
$131B
$384K 0.25%
1,080
-200
-16% -$69.2K
DFIN icon
118
Donnelley Financial Solutions
DFIN
$1.28B
$379K 0.25%
8,050
-14,662
-65% -$636K
KLR
119
DELISTED
Kaleyra, Inc.
KLR
$377K 0.25%
10,739
-1,677
-14% -$63.8K
EMKR
120
DELISTED
Emcore Corp
EMKR
$370K 0.24%
5,300
– –
KWR icon
121
Quaker Houghton
KWR
$2.58B
$360K 0.24%
1,559
– –
LVOX
122
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$356K 0.23%
69,158
+14,489
+27% +$80.2K
ALDX icon
123
Aldeyra Therapeutics
ALDX
$97.1M
$347K 0.23%
86,730
+30,077
+53% +$229K
COWN
124
DELISTED
Cowen Inc. Class A Common Stock
COWN
$346K 0.23%
9,578
-1,487
-13% -$54.5K
OSPN icon
125
OneSpan
OSPN
$584M
$343K 0.23%
20,246
+3,490
+21% +$65.1K
3 4
5
6 7

Similar funds

IPCP
Iron Park Capital Partners New York $621K AUM 73.14% 1-Year Est. Return
EVCM
Emerging Variant Capital Management New York $905K AUM 22.98% 1-Year Est. Return
SHG
Sheares Healthcare Group Singapore $1.69M AUM 4.89% 1-Year Est. Return
EC
EMJ Capital Toronto, Ontario, Canada $3.12M AUM 40.6% 1-Year Est. Return
RIR
Rayliant Investment Research Santa Monica, California $6.94M AUM
FWM
Foresight Wealth Management Draper, Utah $6.98M AUM 13.2% 1-Year Est. Return
SKCP
Storm King Capital Partners New York $8.58M AUM 50.59% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return

Apogem Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Apogem Capital held 220 positions worth $152M, down 3% from $157M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Apogem Capital withdrew a net $9.34M in Q4 2021, closing 46 positions and reducing 54 holdings. Its most notable exit was Synaptics, an estimated $1.45M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Apogem Capital opened a new position in Tecnoglass worth $1.21M.

  • Apogem Capital's largest Q4 2021 buy was Tecnoglass: 46,266 shares worth $1.21M.
  • Apogem Capital added most to Tile Shop Holdings in Q4 2021, an estimated $1.86M increase.
  • Apogem Capital's biggest Q4 2021 reduction was Barclays, cutting an estimated $1.57M.
  • Apogem Capital fully exited Synaptics in Q4 2021, selling an estimated $1.45M.
  • Apogem Capital's ten largest holdings make up 27% of its $152M portfolio in Q4 2021.
  • Apogem Capital opened 35 new positions and closed 46 in Q4 2021.
  • Apogem Capital's portfolio value fell 3% quarter-over-quarter to $152M.

Based on Apogem Capital's 13F filing for Q4 2021, filed 14 Feb 2022.